Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2020-01, Vol.382 (4), p.309-317
Hauptverfasser:	Ladhani, Shamez N, Andrews, Nick, Parikh, Sydel R, Campbell, Helen, White, Joanne, Edelstein, Michael, Bai, Xilian, Lucidarme, Jay, Borrow, Ray, Ramsay, Mary E
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Antigens Child, Preschool Children Children & youth Childrens health Confidence Intervals England - epidemiology Epidemics Estimates Humans Immunization Programs Immunization Schedule Immunization, Secondary Incidence Infant Infant, Newborn Infants Information systems Invasive meningococcal disease Laboratories Meningococcal disease Meningococcal Infections - epidemiology Meningococcal Infections - prevention & control Meningococcal Vaccines - immunology Neisseria meningitidis, Serogroup B Peptides Proteins Public health State Medicine Treatment Outcome United Kingdom Vaccination Vaccine efficacy Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMoa1901229